O'Brien Greene & Co’s Acurx Pharmaceuticals ACXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$30.6K Buy
+3,000
New +$30.6K 0.01% 133